Antibody Drug Conjugate Market, a $13.15 billion Industry by 2030 with a CAGR of 14.12 % New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- The surge in the antibody-drug conjugates market growth is due to rising cancer cases globally, technological advancements in medical...

$4 Billion Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Market Outlook, 2028 Dublin, Dec. 08, 2021 (GLOBE NEWSWIRE) -- The "Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. Market...